Literature DB >> 7964270

The rate of cancellous bone formation falls immediately after ovariectomy in the rat.

J M Lean1, J W Chow, T J Chambers.   

Abstract

We have recently found that administration of oestradiol-17 beta (OE2) to rats stimulates trabecular bone formation. It is not known, however, whether oestrogen has a similar action on bone formation rate under physiological circumstances. Oestrogen is known to suppress bone resorption, and oestrogen-deficient states in the rat, as in humans, are associated with an increase in bone resorption that entrains an increase in bone formation. To see if the latter masks a relative reduction in bone formation, due to oestrogen deficiency, we measured bone formation very early after ovariectomy, before the resorption-induced increase in bone formation becomes established. To do this, rats were administered fluorochrome labels before and after ovariectomy, spaced at weekly intervals in the first, and 3-day intervals in the second experiment. In both experiments there was a decrease in indices of bone formation in the labelling interval immediately following ovariectomy such that, using the shorter fluorochrome intervals, the mineral apposition rate fell to 69%, the double-labelled surface to 45%, and the bone formation rate to 36% of sham-ovariectomized levels. The reduction was not sustained in the subsequent label intervals, presumably masked by the increase in bone formation attributable to increased resorption. These results suggest that if bone formation is assessed before this resorption-entrained increase in bone formation occurs, oestrogen deficiency is associated with a reduction in dynamic indices of bone formation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964270     DOI: 10.1677/joe.0.1420119

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  6 in total

1.  Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand.

Authors:  Jau-Yi Li; Hesham Tawfeek; Brahmchetna Bedi; Xiaoying Yang; Jonathan Adams; Kristy Y Gao; Majd Zayzafoon; M Neale Weitzmann; Roberto Pacifici
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

2.  Effects of estrogen on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in postmenopausal women.

Authors:  Koji Fujita; Matthew M Roforth; Susan Demaray; Ulrike McGregor; Salman Kirmani; Louise K McCready; James M Peterson; Matthew T Drake; David G Monroe; Sundeep Khosla
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

3.  Estrogen suppresses activation but enhances formation phase of osteogenic response to mechanical stimulation in rat bone.

Authors:  C J Jagger; J W Chow; T J Chambers
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

4.  Tetracycline and calcium kinetics are comparable for estimating bone resorption in rats.

Authors:  Yongdong Zhao; Jennifer M K Cheong; WangHee Lee; Meryl Wastney; Berdine R Martin; Connie M Weaver
Journal:  J Nutr       Date:  2010-07-28       Impact factor: 4.798

Review 5.  The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Authors:  Joshua N Farr; Maria Almeida
Journal:  J Bone Miner Res       Date:  2018-08-13       Impact factor: 6.741

6.  Regulation of circulating sclerostin levels by sex steroids in women and in men.

Authors:  Ulrike Il Mödder; Jackie A Clowes; Kelley Hoey; James M Peterson; Louise McCready; Merry Jo Oursler; B Lawrence Riggs; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2011-01       Impact factor: 6.741

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.